Thomas Loew

930 total citations
14 papers, 623 citations indexed

About

Thomas Loew is a scholar working on Hematology, Genetics and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Thomas Loew has authored 14 papers receiving a total of 623 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Hematology, 4 papers in Genetics and 4 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Thomas Loew's work include Acute Myeloid Leukemia Research (6 papers), Acute Lymphoblastic Leukemia research (4 papers) and Hemoglobinopathies and Related Disorders (3 papers). Thomas Loew is often cited by papers focused on Acute Myeloid Leukemia Research (6 papers), Acute Lymphoblastic Leukemia research (4 papers) and Hemoglobinopathies and Related Disorders (3 papers). Thomas Loew collaborates with scholars based in United States, Canada and Australia. Thomas Loew's co-authors include Philip Lee, Joel Charrow, Dominique P. Germain, Anouk C. Vedder, William R. Wilcox, David A. Bushinsky, Nathalie Guffon, Rekha Abichandani, Maryam Banikazemi and Stephen Waldek and has published in prestigious journals such as Blood, Cancer and Journal of the American Society of Nephrology.

In The Last Decade

Thomas Loew

13 papers receiving 597 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thomas Loew United States 9 340 206 164 121 116 14 623
Marta Rozans United States 8 191 0.6× 140 0.7× 86 0.5× 81 0.7× 53 0.5× 13 465
Guy H. Grayson United States 5 193 0.6× 115 0.6× 70 0.4× 43 0.4× 51 0.4× 7 393
Pedro A. deAlarcon United States 5 185 0.5× 106 0.5× 72 0.4× 41 0.3× 111 1.0× 8 446
P Taylor United Kingdom 10 130 0.4× 207 1.0× 67 0.4× 52 0.4× 95 0.8× 17 427
Thomas Fitzmaurice United States 6 301 0.9× 40 0.2× 196 1.2× 71 0.6× 19 0.2× 11 526
Hayri Özsan Türkiye 8 127 0.4× 118 0.6× 60 0.4× 30 0.2× 13 0.1× 21 308
C. F. Lucas United Kingdom 5 90 0.3× 178 0.9× 36 0.2× 31 0.3× 68 0.6× 7 321
V. Leguy‐Seguin France 11 122 0.4× 134 0.7× 48 0.3× 96 0.8× 7 0.1× 28 424
Nobuyuki Hyakuna Japan 11 64 0.2× 148 0.7× 46 0.3× 38 0.3× 64 0.6× 33 364
Masatoshi Takaya Japan 14 117 0.3× 52 0.3× 41 0.3× 111 0.9× 28 0.2× 51 401

Countries citing papers authored by Thomas Loew

Since Specialization
Citations

This map shows the geographic impact of Thomas Loew's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Loew with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Loew more than expected).

Fields of papers citing papers by Thomas Loew

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Loew. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Loew. The network helps show where Thomas Loew may publish in the future.

Co-authorship network of co-authors of Thomas Loew

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Loew. A scholar is included among the top collaborators of Thomas Loew based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Loew. Thomas Loew is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Vlachos, Adrianna, Zora R. Rogers, Jonathan A. Bernstein, et al.. (2020). L‐leucine improves anemia and growth in patients with transfusion‐dependent Diamond‐Blackfan anemia: Results from a multicenter pilot phase I/II study from the Diamond‐Blackfan Anemia Registry. Pediatric Blood & Cancer. 67(12). e28748–e28748. 14 indexed citations
2.
Yang, Zhongbo, Thomas Loew, & Richard Hammer. (2015). Association of long‐term tacrolimus (FK506) therapy with abnormal megakaryocytosis, bone marrow fibrosis, and dyserythropoiesis. Clinical Case Reports. 3(7). 664–668. 3 indexed citations
3.
Yang, Zhongbo, Thomas Loew, & Richard Hammer. (2014). Association of Long-Term Tacrolimus (FK506) Therapy with Abnormal Megakaryocytosis, Bone Marrow Fibrosis, and Dyserythropoiesis. American Journal of Clinical Pathology. 142(suppl_1). A116–A116. 1 indexed citations
4.
Sorrell, April, Todd A. Alonzo, Joanne M. Hilden, et al.. (2012). Favorable survival maintained in children who have myeloid leukemia associated with Down syndrome using reduced‐dose chemotherapy on Children's Oncology Group trial A2971. Cancer. 118(19). 4806–4814. 46 indexed citations
5.
Gamis, Alan S., Todd A. Alonzo, Robert B. Gerbing, et al.. (2011). Natural history of transient myeloproliferative disorder clinically diagnosed in Down syndrome neonates: a report from the Children's Oncology Group Study A2971. Blood. 118(26). 6752–6759. 127 indexed citations
6.
Germain, Dominique P., Stephen Waldek, Maryam Banikazemi, et al.. (2007). Sustained, Long-Term Renal Stabilization After 54 Months of Agalsidase β Therapy in Patients with Fabry Disease. Journal of the American Society of Nephrology. 18(5). 1547–1557. 332 indexed citations
7.
Blumer, Jeffrey L., Stacey L. Berg, Peter C. Adamson, et al.. (2006). Pharmacokinetic evaluation of darbepoetin alfa for the treatment of pediatric patients with chemotherapy‐induced anemia. Pediatric Blood & Cancer. 49(5). 687–693. 4 indexed citations
9.
Loew, Thomas, Alan S. Gamis, Franklin O. Smith, et al.. (2004). Down Syndrome Patients with Relapsed Acute Myelogenous Leukemia.. Blood. 104(11). 4526–4526. 8 indexed citations
10.
Loew, Thomas, Alan S. Gamis, Franklin O. Smith, et al.. (2004). Induction Therapy Failures in Down Syndrome Patients with Acute Myelogenous Leukemia.. Blood. 104(11). 4527–4527. 2 indexed citations
11.
Paulino, Arnold C., Bo Wen, Nina A. Mayr, et al.. (2003). Protracted Radiotherapy Treatment Duration in Medulloblastoma. American Journal of Clinical Oncology. 26(1). 55–59. 23 indexed citations
12.
Goldman, Frederick D., Rajeev Vibhakar, Jennifer M. Puck, et al.. (2002). Aberrant T-Cell Antigen Receptor-Mediated Responses in Autoimmune Lymphoproliferative Syndrome. Clinical Immunology. 104(1). 31–39. 16 indexed citations
13.
Richkind, K, et al.. (1998). Identical Cytogenetic Clones and Clonal Evolution in Pediatric Monozygotic Twins With Acute Myeloid Leukemia. Journal of Pediatric Hematology/Oncology. 20(3). 264–267. 14 indexed citations
14.
Piomelli, Sergio & Thomas Loew. (1991). Management of Thalassemia Major (Cooley’s Anemia). Hematology/Oncology Clinics of North America. 5(3). 557–569. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026